Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer by Wang Yongyu, Kuan Phillip J, Xing Chao, Cronkhite Jennifer T, Torres Fernando, Rosenblatt Randall L, DiMaio J Michael, Kinch Lisa N, Grishin Nick V, Garcia Christine Kim in American journal of human genetics (2009).

[PMID: 19100526] PubMed


Idiopathic pulmonary fibrosis (IPF) is a lethal scarring lung disease that affects older adults. Heterozygous rare mutations in the genes encoding telomerase are found in approximately 15% of familial cases. We have used linkage to map another disease-causing gene in a large family with IPF and adenocarcinoma of the lung to a 15.7 Mb region on chromosome 10. We identified a rare missense mutation in a candidate gene, SFTPA2, within the interval encoding surfactant protein A2 (SP-A2). Another rare mutation in SFTPA2 was identified in another family with IPF and lung cancer. Both mutations involve invariant residues in the highly conserved carbohydrate-recognition domain of the protein and are predicted to disrupt protein structure. Recombinant proteins carrying these mutations are retained in the endoplasmic reticulum and are not secreted. These data are consistent with SFTPA2 germline mutations that interfere with protein trafficking and cause familial IPF and lung cancer.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.